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Summary
Two Swedish families with autosomal dominant my-
opathy, who also had proximal weakness, early respi-
ratory failure, and characteristic cytoplasmic bodies in
the affected muscle biopsies, were screened for linkage
by means of the human genome screening set (Coop-
erative Human Linkage Center Human Screening Set/
Weber version 6). Most chromosome regions were com-
pletely excluded by linkage analysis (LOD score !2).
Linkage to the chromosomal region 2q24-q31 was es-
tablished. A maximum combined two-point LOD score
of 4.87 at a recombination fraction of 0 was obtained
with marker D2S1245. Haplotype analysis indicated
that the gene responsible for the disease is likely to be
located in the 17-cM region between markers D2S2384
and D2S364. The affected individuals from these two
families share an identical haplotype, which suggests a
common origin.
Introduction
In 1990 Edstro¨m et al. described 16 individuals, from
seven families, who had autosomal dominant, adult-on-
set myopathy with early respiratory muscle involvement.
All patients were characterized by proximal weakness
of the upper and lower extremities. In many patients the
respiratory muscles, especially the diaphragm, were in-
volved. Neck flexors were typically affected, and foot
extensor weakness was also present in some patients.
The age at onset of significant symptoms varied from
Received July 10, 1998; accepted for publication January 6, 1999;
electronically published February 17, 1999.
Address for correspondence and reprints: Dr. Zhiping Zhang, De-
partment of Molecular Medicine, Clinical Neurogenetic Unit, CMM-
L8-02-058, Karolinska Hospital, S-17176, Stockholm, Sweden. E-
mail: zhiping.zhang@cmm.ki.se
 1999 by The American Society of Human Genetics. All rights reserved.
0002-9297/99/6403-0016$02.00
the second to the fifth decades, with an average age of
∼35 years. Creatine kinase (CK) levels were normal or
slightly elevated in all cases. Typical muscle biopsy sam-
ples showed, at the light microscopic level, cytoplasmic
bodies that were highly positive for rhodamine-conju-
gated phalloidin. Rhodamine-conjugated phalloidin se-
lectively binds to F-actin. At the ultrastructural level,
these bodies were seen to be composed of thin filaments
and dense material related to the Z-discs.
Subjects and Methods
Genomic DNA was extracted from the peripheral
blood leukocytes of 8 affected and 17 healthy individuals
from two of the seven families described by Edstro¨m et
al. (1990) (fig. 1). All individuals were examined at the
Department of Neurology, O¨rebro Hospital, and most
were seen by L. Edstro¨m and/or L.-G. Gunnarsson. Most
patients underwent a muscle biopsy. A normal dystro-
phin and a-sarcoglycan expression pattern was seen in
the muscle tissue. Most patients fulfilled the diagnostic
criteria for autosomal dominant limb-girdle muscular
dystrophy (LGMD) (Bushby 1995): onset of the disease
in the pelvic or shoulder girdle muscles, inevitable and
slow progression of symptoms, normal to mildly raised
serum CK activity, and myopathic changes on electro-
myography (EMG) and on muscle biopsy. Because mus-
cle necrosis and fibrosis were not evident in the muscle
biopsy samples from affected patients, the disorder de-
scribed by Edstro¨m et al. (1990) was defined as an au-
tosomal dominant myopathy and not as an LGMD. The
study protocol was accepted by the ethical board at O¨r-
ebro Hospital (1995-05-15).
Genotype Analysis
Three hundred ninety-one microsatellite markers from
the Cooperative Human Linkage Center (CHLC) Hu-
man Screening Set/Weber version 6 were used for the
initial screening. Additional markers from Research Ge-
netics were applied. Genotypes were determined by PCR
amplification using 33P-labeled nucleotides. PCR reac-
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Figure 1 Haplotypes of two Swedish families (A and B) who had autosomal dominant myopathy, with markers fromD2S1353 toD2S1384.
Haplotypes were constructed assuming a minimum number of recombinations. The haplotype segregating with the disease is boxed. A question
mark (?) indicates unknown phenotype.
tions were performed on 96-well microtiter plates in 10-
ml reaction volumes containing 50 ng of genomic DNA,
2 pmol of each primer, and 0.5 U of Taq polymerase
(Sigma). The conditions for PCR were 95C for 1 min,
55C–60C for 1 min, and 72C for 1 min, with a final
extension step of 72C for 7 min. The PCR products
were separated on 6% denaturing polyacrylamide gels.
The alleles were visualized by autoradiography.
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Table 1
Combined Pairwise LOD Scores between the Disease Gene and




LOD SCORE AT v 
.00 .001 .005 .010 .020 .30 .40
D2S1353 2  .28 1.36 1.55 1.29 .73 .19
D2S2395 2.9 1.61 1.60 1.51 1.39 1.09 .75 .37
D2S2157 0  1.93 2.33 2.25 1.73 1.04 .37
D2S2330 0  2.83 3.19 3.06 2.43 1.59 .67
D2S2363 0 2.80 2.75 2.54 2.26 1.65 1.0 .36
D2S2384 1.6 3.82 3.74 3.45 3.07 2.23 1.33 .47
D2S2345 2 4.47 4.38 4.01 3.54 2.54 1.47 .50
D2S1776 2.9 2.89 2.83 2.58 2.27 1.63 .97 .34
D2S333 0 4.22 4.14 3.79 3.34 2.38 1.37 .40
D2S335 0 4.26 4.18 3.85 3.42 2.49 1.51 .50
D2S2302 1.6 4.07 3.99 3.66 3.23 2.31 1.34 .41
D2S1238 5 4.20 4.11 3.78 3.34 2.42 1.42 .46
D2S1245 .4 4.87 4.78 4.41 3.93 2.89 1.78 .67
D2S138 1.1 4.64 4.55 4.18 3.71 2.68 1.59 .57
D2S324 1.1 4.52 4.43 4.06 3.59 2.58 1.52 .52
D2S384 0 1.63 1.62 1.53 1.41 1.13 .79 .40
D2S2310 0 3.05 3.00 2.79 2.48 1.80 1.03 .28
D2S2978 1.1 4.75 4.66 4.29 3.82 2.80 1.71 .66
D2S364 0 .45 2.46 2.81 2.65 1.99 1.16 .40
D2S1391 14.2  1.06 .15 .50 .54 .31 .08
D2S1384  1.25 1.71 1.70 1.34 .82 .32
a Estimated distance from the next marker in centimorgans accord-
ing to the Marshfield Medical Research Foundation’s Chromosome 2
Sex-Averaged linkage map.
Two-Point Linkage Analysis
Two-point LOD scores were calculated by using the
MLINK program, as implemented in the FASTLINK
package, version 3.0P (Lathrop and Lalouel 1984; Cot-
tingham et al. 1993; Terwilliger and Ott 1994). The
order and the approximate distances of the markers were
obtained from the Ge´ne´thon integrated map and the
Marshfield Medical Research Foundation’s Chromo-
some 2 Sex-Averaged linkage map. The frequency of the
disease gene in the population was assumed to be 1:
10,000, with an autosomal dominant inheritance pattern
and 100% penetrance. Allele frequencies and male/fe-
male recombination fractions were assumed to be equal.
Haplotypes were constructed by assuming a minimum
number of recombinations. In the linkage analysis, be-
cause of the late onset of the symptoms, the disease status
of individuals aged !25 years was coded as unknown
(individual III:1 in family B).
Results
A whole-genome screen, using the CHLC Human
Screening Set/Weber version 6, was performed for the
two Swedish families with this autosomal dominant my-
opathy. The screening set consists of 391 markers with
an average distance interval of 10 cM. Because of the
clinical similarity between the present myopathy and the
autosomal dominant LGMD, haplotype analysis was
performed for candidate regions of LGMD1A, 1B, and
1C (5q22-q31, 1q11-q21, and 3p25). The possibility
that the described disease could represent an allelic form
of these LGMDs was completely excluded. Except for
the region of 2q24-q31, most chromosome regions were
excluded by linkage and haplotype analysis (LOD score
! 2). A positive LOD score (2.29 at recombination
fraction [v] of zero) was obtained in family A with
marker D2S1776, located on chromosome 2q24. Ad-
ditional highly informative markers close to D2S1776
were used to confirm or exclude the linkage. Linkage
to this region was established. A combined maximum
LOD score of 4.87 was obtained at v  0 with marker
D2S1245 (table 1). This is the highest LOD score at-
tainable in these two families (A and B).
All affected individuals from family A share a com-
mon haplotype that spans the region from D2S2395 to
D2S2978. In family B, the region shared by the affected
individuals extends from D2S2345 to D2S1391 (fig. 1).
Loci that are proximal to D2S2384 are excluded by a
recombination event in individual II:2 from family B.
Exclusion of loci that are distal to D2S364 is based on
a recombination event in family A that has resulted in
the presence of different haplotypes in the affected in-
dividuals: III:4, III:5, IV:2, and IV:4. All affected indi-
viduals from these two families share an identical hap-
lotype from D2S2345 to D2S2978, suggesting a com-
mon origin (results obtained with the most informative
markers are summarized in table 1).
Discussion
Respiratory muscle involvement is a common occur-
rence in the late stages of many muscular dystrophies,
such as Duchenne muscular dystrophy and myotonic
dystrophy. Disorders with early respiratory involvement
include, together with our myopathy, acid maltase de-
ficiency in adults (MIM232300) (Rosenow and Engel
1978) and nemaline myopathy (NEM2; MIM 256030)
(Dubowitz 1978). Many patients in the families inves-
tigated required assisted ventilation a few years after the
onset of symptoms. A peculiar characteristic of the pa-
tients described by Edstro¨m et al. (1990) was the pres-
ence of cytoplasmic bodies in the muscle fibers. These
bodies stain with rhodamine-conjugated phalloidin and,
at the ultrastructural level, appear to be composed of
filamentous material.
Tibial muscular dystrophy (TMD; MIM 600334), a
relatively rare autosomal dominant myopathy, has re-
cently been mapped to chromosome 2q31 between the
markers D2S2188 and D2S2310 (Haravuori et al.
1998). This locus is completely included in our mapping
region, and the two diseases have some features in com-
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mon, such as autosomal dominant inheritance, late on-
set, and normal to slightly elevated serum CK levels.
Some patients described by Edstro¨m et al. (1990) had
early involvement of dorsal foot extensors. Additional
clinical and histological findings reveal that the two dis-
eases are, in fact, different. In TMD the weakness is
usually limited to the tibial anterior muscles, and the
myopathic changes evident in the muscle biopsy samples
are unspecific (Udd et al. 1992, 1993). Similarly,
LGMD2B (MIM 253601) and two distal myopa-
thies—Miyoshi myopathy (MM; MIM 254130) and We-
lander distal myopathy (MIM 160500)—have been
mapped to the same region of chromosome 2p12-p14
(Bashir et al. 1994, 1996; Bejaoui et al. 1995, 1998;
A˚hlberg G, Borg K, Edstro¨m L, Anvret M, unpublished
data). LGMD2B and Miyoshi myopathy are both caused
by mutations of the Dysferlin gene (MIM 603009)
(Bashir et al. 1998; Liu et al. 1998). This raises the
possibility that the disorder described by Edstro¨m et al.
(1990) and TMD might represent allelic variants of the
same gene.
The autosomal recessive form of nemaline myopathy
has been mapped by linkage analysis to a 13-cM region
of chromosome 2q21.2-q22 between the markers
D2S150 and D2S142 (Wallgren-Pettersson et al. 1995).
This region is ∼8 cM proximal to our region and con-
tains the Nebulin gene (MIM 161650). Nebulin is con-
sidered to be a functional candidate gene for nemaline
myopathy (Labeit and Kolmerer 1995a; Pelin et al.
1997). Recessive nemaline myopathy and the present
disease share some clinical and pathological findings.
Tissue from the muscle biopsy samples from patients
with nemaline myopathy, however, shows a regular lat-
tice pattern by electron microscopy that characterizes
the rod bodies (Fardeau 1982). In addition, the region
of 2q21.2-q22 is excluded for our patients by linkage
and haplotype analysis (LOD score ! 2 at v  0 for
the markers D2S1792, D2S1399, and D2S2299, which,
according to the sex-averaged linkage map of the Marsh-
field Medical Research Foundation, map within the re-
cessive nemaline myopathy locus).
The present disease is located on a 17-cM region on
chromosome 2q24-q31. Several candidate genes, among
which are some specifically expressed in the muscle, map
within this area. The Titin gene (MIM 188840) is con-
sidered to be a functional candidate for our myopathy.
Titin, or connectin, is the largest polypeptide known and
forms, together with nebulin, the third filament system
of the striated muscle fibers. Titin molecules form fila-
ments 11mm long (Nave et al. 1989; Suzuki et al. 1994),
which span from the Z-discs to the M-lines (Fu¨rst et al.
1988). This filament system accounts for the passive ten-
sion of the resting muscle and contributes to the assem-
bly of striated muscle myofibrils (Labeit and Kolmerer
1995b). The whole coding region of the gene (∼300 kb)
maps within our candidate region, between the markers
D2S335 and D2S364 (Pelin et al. 1997).
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